MoneyWorks4Me

Zydus Lifesciences informs about press release

25 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 25, 2025, titled ‘Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..